Octagon Capital

Investments by market, targeted sectors and preferred funding rounds

Name - Octagon Capital
Web - none
Description -
Investor Type -
Preferred rounds -
Location

Investments by industry

healthtech - 33%
biotech - 67%

Number of investments: 3

Octagon Capital invested in Aktis Oncology during a round worth $72,000,000 - 3/18/2021
Octagon Capital invested in StrideBio during a round worth $81,500,000 - 3/16/2021
Octagon Capital invested in Century Therapeutics during a round worth $160,000,000 - 3/4/2021